Ningbo Sanxing Medical Electric Co.,Ltd. (SHA:601567)

SHA:601567 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	14,990	14,384	11,261	8,939	6,911	6,995
Other Revenue	216.26	216.26	201.71	158.82	112.31	97.95
Revenue	15,206	14,600	11,463	9,098	7,023	7,093
Revenue Growth (YoY)	24.25%	27.38%	25.99%	29.55%	-0.98%	4.22%
Cost of Revenue	10,084	9,584	7,600	6,487	5,259	5,066
Gross Profit	5,122	5,017	3,862	2,611	1,764	2,027
Selling, General & Admin	1,960	1,914	1,626	1,188	845.78	771.53
Research & Development	525.02	515.58	463.77	320.81	285.94	298.71
Other Operating Expenses	-78.32	-71.88	19.11	23.36	40.92	22.41
Operating Expenses	2,461	2,382	2,134	1,522	1,215	1,067
Operating Income	2,662	2,635	1,729	1,089	548.89	959.69
Interest Expense	-106.15	-95	-52.75	-61.33	-83.25	-28.45
Interest & Investment Income	288.91	304.98	342.58	123.66	239.61	360.29
Currency Exchange Gain (Loss)	-111.94	-111.94	40.92	55	-32.97	-79.98
Other Non Operating Income (Expenses)	60.38	-31.01	-30.67	-17.45	42.5	-113.7
EBT Excluding Unusual Items	2,793	2,702	2,029	1,189	714.77	1,098
Impairment of Goodwill	-13.6	-13.6	-8.68	-9.49	-1.79	-15.48
Gain (Loss) on Sale of Investments	-133.82	-177.13	132.41	-107.48	103.7	65.38
Gain (Loss) on Sale of Assets	-0.4	-0.04	-0.1	-1.88	-7.65	-4.9
Asset Writedown	-12.07	-11.31	-1.67	1.57	-4.59	-0.08
Other Unusual Items	172.96	172.96	111.46	80.78	42.38	45.75
Pretax Income	2,806	2,673	2,262	1,152	846.81	1,189
Income Tax Expense	416.55	399.32	341.26	187.04	139.2	227.65
Earnings From Continuing Operations	2,389	2,273	1,921	965.01	707.61	960.88
Minority Interest in Earnings	-4.81	-13.72	-17.1	-16.89	-17.57	-4.76
Net Income	2,385	2,260	1,904	948.12	690.04	956.12
Net Income to Common	2,385	2,260	1,904	948.12	690.04	956.12
Net Income Growth	19.32%	18.69%	100.79%	37.40%	-27.83%	-4.81%
Shares Outstanding (Basic)	1,411	1,412	1,410	1,415	1,380	1,386
Shares Outstanding (Diluted)	1,411	1,412	1,410	1,415	1,380	1,386
Shares Change (YoY)	0.40%	0.14%	-0.35%	2.54%	-0.40%	-0.67%
EPS (Basic)	1.69	1.60	1.35	0.67	0.50	0.69
EPS (Diluted)	1.69	1.60	1.35	0.67	0.50	0.69
EPS Growth	18.84%	18.52%	101.49%	34.00%	-27.54%	-4.17%
Free Cash Flow	526.2	791.63	1,345	818.7	-96.3	1,024
Free Cash Flow Per Share	0.37	0.56	0.95	0.58	-0.07	0.74
Dividend Per Share	0.890	0.890	0.650	0.350	0.320	0.350
Dividend Growth	36.92%	36.92%	85.71%	9.38%	-8.57%	66.67%
Gross Margin	33.68%	34.36%	33.69%	28.70%	25.11%	28.57%
Operating Margin	17.50%	18.05%	15.08%	11.97%	7.82%	13.53%
Profit Margin	15.68%	15.48%	16.61%	10.42%	9.83%	13.48%
Free Cash Flow Margin	3.46%	5.42%	11.74%	9.00%	-1.37%	14.44%
EBITDA	2,931	2,901	1,981	1,317	744.1	1,147
EBITDA Margin	19.28%	19.87%	17.29%	14.48%	10.60%	16.17%
D&A For EBITDA	269.39	266.07	252.77	228.7	195.22	187.11
EBIT	2,662	2,635	1,729	1,089	548.89	959.69
EBIT Margin	17.50%	18.05%	15.08%	11.97%	7.82%	13.53%
Effective Tax Rate	14.85%	14.94%	15.09%	16.23%	16.44%	19.15%
Revenue as Reported	15,206	14,600	11,463	9,098	7,023	7,093
Advertising Expenses	-	32.21	18.07	11.28	8.04	7.54

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.